YENOM NOTICIAS

Qué está moviendo el mercado.

Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.

ASTX
Limpiar

Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.

finance.yahoo.comPOSITIVO

Tradr ETFs Surpasses $2 Billion in Assets and Doubles AUM Since August

Reflects strong enthusiasm for the Tradr family of single-stock and calendar reset leveraged ETFs NEW YORK, Oct. 10, 2025 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, announc…

finance.yahoo.comPOSITIVO

Tradr Unveils First-to-Market Leveraged ETFs on Lam Research & MongoDB

Two new 2X long single-stock ETFs focused on high-growth tech companies NEW YORK, Aug. 19, 2025 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today announced the launch of two…

finance.yahoo.comPOSITIVO

Athersys Announces CEO Transition

Gil Van Bokkelen to Step Down as Chairman and CEO; B.J. Lehmann Appointed Interim CEO Board Initiating Search for Permanent Successor; Ismail Kola appointed Chairman of the Board Company Postpones Investor Day Athersys, Inc. (Nasdaq: ATHX)…

finance.yahoo.comPOSITIVO

Athersys Announces CEO Transition

Gil Van Bokkelen to Step Down as Chairman and CEO; B.J. Lehmann Appointed Interim CEO Board Initiating Search for Permanent Successor; Ismail Kola appointed Chairman of the Board Company Postpones Investor Day Athersys, Inc. (Nasdaq: ATHX)…

globenewswire.comPOSITIVO

Cortex Pharmaceuticals, Inc. Announces Name Change and Symbol Change

GLEN ROCK, NJ--(Marketwired - Dec 17, 2015) - Cortex Pharmaceuticals, Inc. (OTC: CORX) (the "Company") is providing investors and shareholders with a 2015 year-end update and a summary overview of the Company's clinical trial plans for 201…

globenewswire.comPOSITIVO

Cortex Pharmaceuticals, Inc. Announces Appointment of James S. J. Manuso, Ph.D., as President and Chief Executive Officer, Vice Chairman of the Board of Directors

GLEN ROCK, NJ--(Marketwired - Aug 19, 2015) - Cortex Pharmaceuticals, Inc. (OTCQB: CORX) ("Cortex" or the "Company"), a leader in the discovery and development of innovative pharmaceuticals for the treatment of breathing disorders, today a…